The Seraseq® 22q11 Female - Matched Reference Material is intended for use in Whole Genome or Targeted Next Generation Sequencing (NGS) assays, dPCR, or microarray assays that screen for 22q11 (DiGeorge syndrome) chromosomal abnormalities in cell-free fetal DNA (cfDNA). Seraseq® 22q11 Female - Matched Reference Material is derived from DNA extracted from a pregnant patient source sample carrying a female fetus with confirmed 22q11 microdeletion. This product is available in a plasma format, enabelling the assessing the complete workflow from extraction through to analysis, similar to clinical samples. This reference material is intended for researchers and Non-Invasive Prenatal Testing (NIPT) labs to monitor library preparation, sequencing, and detection performance.